BIOMAT Database Logo BIOMAT Database Logo

[Successful renal contraction therapy in polycystic kidney patient with renal transcatheter arterial embolization prior to ABO incompatible kidney transplantation]. 2010

Taigo Kato, and Koji Yazawa, and Naotsugu Ichimaru, and Jun Saito, and Koichi Tsutahar, and Yoichi Kakuta, and Toyofumi Abe, and Yasutomo Nakai, and Norio Nonomura, and Shiro Takahara, and Akihiko Okuyama
Department of Specific Organ Regulation (Urology), Osaka University Graduate School of Medicine.

28-year-old female received dialysis treatment due to chronic renal failure caused by polycystic kidney disease. Later, she underwent a laparoscopic splenectomy and ABO incompatible living kidney transplantation successfully following bilateral renal contraction therapy with renal transcatheter arterial embolization (renal TAE). A unilateral or bilateral native nephrectomy of a massively enlarged kidney performed at the time of renal transplantation is a common treatment in polycystic kidney patients scheduled for transplantation. On the other hand, when treated with renal TAE, such patients can avoid a laparotomy, which provides several advantages when undergoing peritoneal dialysis in the future or a laparoscopic splenectomy prior to ABO incompatible kidney transplantation. Furthermore, we consider that bilateral renal TAE is necessary for polycystic kidney patients prior to renal transplantation for a variety of reasons, including problems associated with contrast nephropathy if renal TAE for left kidney is remained after renal transplantation.

UI MeSH Term Description Entries
D007668 Kidney Body organ that filters blood for the secretion of URINE and that regulates ion concentrations. Kidneys
D007690 Polycystic Kidney Diseases Hereditary diseases that are characterized by the progressive expansion of a large number of tightly packed CYSTS within the KIDNEYS. They include diseases with autosomal dominant and autosomal recessive inheritance. Kidney, Polycystic,Polycystic Kidney,Polycystic Kidney Disease,Polycystic Kidneys,Polycystic Renal Disease,Disease, Polycystic Kidney,Disease, Polycystic Renal,Diseases, Polycystic Kidney,Diseases, Polycystic Renal,Kidney Disease, Polycystic,Kidney Diseases, Polycystic,Kidneys, Polycystic,Polycystic Renal Diseases,Renal Disease, Polycystic,Renal Diseases, Polycystic
D012077 Renal Artery A branch of the abdominal aorta which supplies the kidneys, adrenal glands and ureters. Arteries, Renal,Artery, Renal,Renal Arteries
D001787 Blood Group Incompatibility An antigenic mismatch between donor and recipient blood. Antibodies present in the recipient's serum may be directed against antigens in the donor product. Such a mismatch may result in a transfusion reaction in which, for example, donor blood is hemolyzed. (From Saunders Dictionary & Encyclopedia of Laboratory Medicine and Technology, 1984). ABO Compatibility,ABO Incompatibility,Blood Group ABO Incompatibility,Blood Type Incompatibility,Rh Compatibility,Rh Incompatibility,ABO Compatibilities,ABO Incompatibilities,Blood Group Incompatibilities,Blood Type Incompatibilities,Compatibility, ABO,Compatibility, Rh,Incompatibilities, Blood Group,Incompatibility, ABO,Incompatibility, Blood Group,Incompatibility, Blood Type,Incompatibility, Rh,Rh Compatibilities,Rh Incompatibilities
D004621 Embolization, Therapeutic A method of hemostasis utilizing various agents such as Gelfoam, silastic, metal, glass, or plastic pellets, autologous clot, fat, and muscle as emboli. It has been used in the treatment of spinal cord and INTRACRANIAL ARTERIOVENOUS MALFORMATIONS, renal arteriovenous fistulas, gastrointestinal bleeding, epistaxis, hypersplenism, certain highly vascular tumors, traumatic rupture of blood vessels, and control of operative hemorrhage. Embolotherapy,Therapeutic Embolization,Embolizations, Therapeutic,Embolotherapies,Therapeutic Embolizations
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000017 ABO Blood-Group System The major human blood type system which depends on the presence or absence of two antigens A and B. Type O occurs when neither A nor B is present and AB when both are present. A and B are genetic factors that determine the presence of enzymes for the synthesis of certain glycoproteins mainly in the red cell membrane. ABH Blood Group,ABO Blood Group,ABO Factors,Blood Group H Type 1 Antigen,H Blood Group,H Blood Group System,ABO Blood Group System,Blood Group, ABH,Blood Group, ABO,Blood Group, H,Blood-Group System, ABO,Factors, ABO,System, ABO Blood-Group
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D016030 Kidney Transplantation The transference of a kidney from one human or animal to another. Grafting, Kidney,Renal Transplantation,Transplantation, Kidney,Transplantation, Renal,Kidney Grafting,Kidney Transplantations,Renal Transplantations,Transplantations, Kidney,Transplantations, Renal

Related Publications

Taigo Kato, and Koji Yazawa, and Naotsugu Ichimaru, and Jun Saito, and Koichi Tsutahar, and Yoichi Kakuta, and Toyofumi Abe, and Yasutomo Nakai, and Norio Nonomura, and Shiro Takahara, and Akihiko Okuyama
[Transcatheter renal arterial embolization therapy on patients with polycystic kidney disease].
January 2013, Nihon Jinzo Gakkai shi,
Taigo Kato, and Koji Yazawa, and Naotsugu Ichimaru, and Jun Saito, and Koichi Tsutahar, and Yoichi Kakuta, and Toyofumi Abe, and Yasutomo Nakai, and Norio Nonomura, and Shiro Takahara, and Akihiko Okuyama
Transcatheter renal arterial embolization therapy on a patient with polycystic kidney disease on hemodialysis.
November 1999, American journal of kidney diseases : the official journal of the National Kidney Foundation,
Taigo Kato, and Koji Yazawa, and Naotsugu Ichimaru, and Jun Saito, and Koichi Tsutahar, and Yoichi Kakuta, and Toyofumi Abe, and Yasutomo Nakai, and Norio Nonomura, and Shiro Takahara, and Akihiko Okuyama
Successful ABO-incompatible kidney transplantation in patient with congenital afibrinogenemia.
September 2012, Transplant international : official journal of the European Society for Organ Transplantation,
Taigo Kato, and Koji Yazawa, and Naotsugu Ichimaru, and Jun Saito, and Koichi Tsutahar, and Yoichi Kakuta, and Toyofumi Abe, and Yasutomo Nakai, and Norio Nonomura, and Shiro Takahara, and Akihiko Okuyama
[Transcatheter arterial embolization (TAE) therapy on a patient with polycystic kidney disease].
January 2012, Nihon Jinzo Gakkai shi,
Taigo Kato, and Koji Yazawa, and Naotsugu Ichimaru, and Jun Saito, and Koichi Tsutahar, and Yoichi Kakuta, and Toyofumi Abe, and Yasutomo Nakai, and Norio Nonomura, and Shiro Takahara, and Akihiko Okuyama
Successful peritoneal dialysis after renal transcatheter arterial embolization in autosomal dominant polycystic kidney disease.
November 2011, American journal of kidney diseases : the official journal of the National Kidney Foundation,
Taigo Kato, and Koji Yazawa, and Naotsugu Ichimaru, and Jun Saito, and Koichi Tsutahar, and Yoichi Kakuta, and Toyofumi Abe, and Yasutomo Nakai, and Norio Nonomura, and Shiro Takahara, and Akihiko Okuyama
Renal contraction therapy for enlarged polycystic kidneys by transcatheter arterial embolization in hemodialysis patients.
March 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation,
Taigo Kato, and Koji Yazawa, and Naotsugu Ichimaru, and Jun Saito, and Koichi Tsutahar, and Yoichi Kakuta, and Toyofumi Abe, and Yasutomo Nakai, and Norio Nonomura, and Shiro Takahara, and Akihiko Okuyama
Successful pregnancy after ABO-incompatible kidney transplantation.
April 2016, Transplant international : official journal of the European Society for Organ Transplantation,
Taigo Kato, and Koji Yazawa, and Naotsugu Ichimaru, and Jun Saito, and Koichi Tsutahar, and Yoichi Kakuta, and Toyofumi Abe, and Yasutomo Nakai, and Norio Nonomura, and Shiro Takahara, and Akihiko Okuyama
Kidney Transplantation After Renal Transcatheter Arterial Embolization for Cyst Infection in a Hemodialysis Patient With Autosomal Dominant Polycystic Kidney Disease: A Case Report.
May 2023, Transplantation proceedings,
Taigo Kato, and Koji Yazawa, and Naotsugu Ichimaru, and Jun Saito, and Koichi Tsutahar, and Yoichi Kakuta, and Toyofumi Abe, and Yasutomo Nakai, and Norio Nonomura, and Shiro Takahara, and Akihiko Okuyama
Tacrolimus therapy for ABO-incompatible kidney transplantation.
June 1998, Transplantation proceedings,
Taigo Kato, and Koji Yazawa, and Naotsugu Ichimaru, and Jun Saito, and Koichi Tsutahar, and Yoichi Kakuta, and Toyofumi Abe, and Yasutomo Nakai, and Norio Nonomura, and Shiro Takahara, and Akihiko Okuyama
ABO incompatible kidney transplantation.
November 2007, Current opinion in nephrology and hypertension,
Copied contents to your clipboard!